Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

ANDA Approvals, Submissions Decline With New Review Goal Coming

Executive Summary

Is a rush of generic applications seeking the 10-month clock on the way?

Advertisement

Related Content

ANDA Approvals, Complete Responses Hit Record In FY 2016
FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs
GDUFA II: ANDAs, Not Facilities Will Govern Revenue
ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal
GDUFA II Will Include Small Business Relief, Priority ANDA Reviews
ANDA User Fees Offer Sponsor Relief, But More Facility Pain
ANDA Approval Speed-Up Leaves Sponsors With Less Margin For Error
ANDA Reviews: First-Cycle Desired, But Two-Cycles OK?
ANDA Submission Lull Is Now A Trend, As Are Sluggish Approval Numbers
GDUFA Performance Goals For Fiscal Years 2013-2017

Topics

Advertisement
UsernamePublicRestriction

Register

PS118956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel